Skip to main content

Environmental causes of cancer in man

  • Chapter
Book cover Biology of Carcinogenesis

Part of the book series: Cancer Biology and Medicine ((CABM,volume 1))

  • 40 Accesses

Abstract

While screening programmes can reduce mortality from cervical cancer, and to a lesser extent, that from breast cancer1, the early detection of other cancers and the treatment of established disease are likely to have a rather limited impact in reducing mortality due to the major human cancers. It has been estimated, for example, that, while modern surgery is effective in significantly decreasing cancer mortality, use of additional types of treatment (e.g., X-ray, chemotherapy) after surgery could result in no more than a 5% reduction in the number of deaths from cancer each year2. These considerations emphasize the importance of primary prevention of cancer, which involves the identification of the causes of human cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Morrison, A. S. (1985). Screening in Chronic Disease. (New York: Oxford University Press)

    Google Scholar 

  2. Cairns, J. (1985). The treatment of diseases and the war against cancer. Sei. Am., 253, 31–39

    Google Scholar 

  3. Parkin, D. M., Stjernswärd, J. and Muir, C. S. (1984). Estimates of the worldwide frequency of twelve major cancers. Bull. WHO, 62, 163–182

    PubMed  CAS  Google Scholar 

  4. Haenszel, W, and Kurihara, M. (1968). Studies of Japanese migrants. In: Mortality from cancer and other diseases among Japanese in the United States. J. Natl. Cancer Inst., 40, 43–68

    PubMed  CAS  Google Scholar 

  5. Kmet, J. (1970). The role of migrant populations in studies of selected cancer. J. Chron. Dis., 23, 305–324

    PubMed  CAS  Google Scholar 

  6. U.S. Public Health Service (1980). Populations at low risk of cancer: cancer patterns in ethnic groups. Natl Cancer Inst., 65, 1127–1159

    Google Scholar 

  7. Wynder, E. L. and Gori, G. B. (1977). Contribution of the environment to cancer incidence: an epidemiologic exercise. J. Natl Cancer Inst., 58, 825–832

    PubMed  CAS  Google Scholar 

  8. Higginson, J. and Muir, C. S. (1979). Environmental carcinogenesis: misconceptions and limitations to cancer control. J. Natl Cancer Inst., 63, 1294–1298

    Google Scholar 

  9. Doll, R. and Peto, R. (1981). The Causes of Cancer. (Oxford: Oxford University Press, Oxford Medical Publications)

    Google Scholar 

  10. McMahon, B. and Pugh, T. F. (1970). Epidemiology, Principles and Methods. (Boston: Little Brown Co.)

    Google Scholar 

  11. Terris, M. (1968). A social policy for health. Am. J. Public Health, 58, 5–12

    CAS  Google Scholar 

  12. National Research Council (1982). Diet, Nutrition and Cancer. (Washington: National Academy Press)

    Google Scholar 

  13. Graham, S. (1983). Toward a dietary prevention of cancer. Epidemiol Rev, 5, 38–50

    PubMed  CAS  Google Scholar 

  14. Willett, W. C. and McMahon, B. (1984). Diet and cancer: An overview . N. Engl. J. Med., 310, 633–638 and 697–703

    Google Scholar 

  15. Zaridze, D. G., Muir, C. S. and McMichael, A. J. (1985). Diet and cancer: Value of different types of epidemiological studies. Nutr. Cancer, 7, 155–166

    PubMed  CAS  Google Scholar 

  16. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans (1972–1985). Vols. 1 to 38. (Lyon: International Agency for Research on Cancer)

    Google Scholar 

  17. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans (1982). Chemicals, Industrial Processes and Industries Associated with Cancer in Humans. Supplement 4. (Lyon: International Agency for Research on Cancer)

    Google Scholar 

  18. Tomatis, L. (1986). The contribution of the I ARC Monographs programme to the identification of cancer risk factors. N. Y. Acad. Sci. (In press)

    Google Scholar 

  19. Vainio, H., Hemminki, K. and Wilbourn, J. (1985). Data on the carcinogenicity of chemicals in the I ARC Monographs programme. Carcinogenesis, 6, 1653–1665

    PubMed  CAS  Google Scholar 

  20. Merletti, F., Heseltine, E., Saracci, R., Simonato, L., Vainio, H. and Wilbourn, J. (1984). Target organs for carcinogenicity of chemicals and industrial exposures in humans: A review of results in the IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Cancer Res., 44, 2244–2250

    PubMed  CAS  Google Scholar 

  21. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans Vol. 33. Poly nuclear Aromatic Compounds, Part 2. Carbon Blacks, Mineral Oils and some Nitroarene Compounds. (Lyon: International Agency for Research on Cancer)

    Google Scholar 

  22. Hunter, D. (ed.) (1975). The Disease of Occupations. 5th Edn., pp. 773–783. (London: The English Universities Press Ltd.)

    Google Scholar 

  23. Rehn, L. (1985). Blasenbeschwulste bei Fuchs in Arbeitern. Arch. Klin. Chir., 50, 588–600

    Google Scholar 

  24. International Labour Office, Geneva, 23 February 1921, Studies and Reports, Series No. 1

    Google Scholar 

  25. Case, R. A. M., Hosker, M. E., McDonald, D. B. and Pearson, J. T. (1954). Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Part I. The role of aniline, benzidine, a- naphthylamine and j8-naphthylamine. Br. J. Ind. Med., 11, 75

    PubMed  CAS  Google Scholar 

  26. Walpole, A. L., Williams, M. H. C. and Roberts, D. C. (1954). Tumours of the urinary bladder in dogs after ingestion of 4-aminodiphenyl. Br. J. Ind. Med., 11, 105

    PubMed  CAS  Google Scholar 

  27. Melick, W. F., Naryka, J. J. and Kelly R. E. (1971). Bladder cancer due to exposure to para-aminobiphenyl: a 17-year fellowship. J. Urol., 106, 220–226

    PubMed  CAS  Google Scholar 

  28. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. (1977). Vol. 14. Asbestos. (Lyon: International Agency for Research on Cancer)

    Google Scholar 

  29. Tomatis, L. (1985). The contribution of epidemiological and experimental data to the control of environmental carcinogens. Cancer Lett., 26, 5–16

    PubMed  CAS  Google Scholar 

  30. Reimer R. R., Hoover, R., Fraumeni, J. F. and Young, R. C. (1977). Acute leukemia after alkylating agent therapy of ovarian cancer. N. Engl. J. Med., 297, 177–181

    PubMed  CAS  Google Scholar 

  31. Boice, J. D., Greene, M. H., Killen, J. Y., Susan, M. D., Ellenberg, S. S., Keehn, R. J., McFadden, E., Chen, T. T. and Fraumeni, J. F. (1984). Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU). N. Engl. J. Med., 309, 1079–1081

    Google Scholar 

  32. Rajewsky, M. F. and Huh, N. (1984). Molecular and cellular mechanisms underlying ineffective cancer chemotherapy. Recent Results Cancer Res., 96, 18–29

    PubMed  CAS  Google Scholar 

  33. Gastrointestinal Tumor Study Group (1984). Adjuvant therapy of colon cancer — Results of a prospectively randomized trial. N. Engl. J. Med., 310, 737–743

    Google Scholar 

  34. Gastrointestinal Tumor Study Group (1985). Prolongation of the disease-free interval in surgically treated rectal carcinoma. N. Engl. J. Med., 312, 1465–1472

    Google Scholar 

  35. IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans (1979). Vol. 21. Sex Hormones. (Lyon: International Agency for Research on Cancer)

    Google Scholar 

  36. IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans Vol. 37. Tobacco Habits other than Smoking: Betel-quid and Areca-nut Chewing; and some Related Nitrosamines. (Lyon; International Agency for Research on Cancer)

    Google Scholar 

  37. Hirayama, T. (1966). An epidemiological study of oral and pharyngeal cancer in Central and South East Asia. Bull WHO, 34, 41–69

    PubMed  CAS  Google Scholar 

  38. IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans (1985). Vol. 38. Tobacco Smoking. (Lyon: International Agency for Research on Cancer)

    Google Scholar 

  39. Whittemore, A. S. and MacMillan, A. (1983). Lung cancer mortality among U.S. uranium miners: a reappraisal. J. Natl. Cancer Inst., 71, 489–499

    PubMed  CAS  Google Scholar 

  40. Hammond, E.C., Selikoff, I. J. and Seidman, H. (1979). Asbestos exposure, cigarette smoking and death rates. Ann. N. Y. Acad. Sci., 330, 473–490

    PubMed  CAS  Google Scholar 

  41. Rothman, K. and Keller, R. (1972). The effect of joint exposure of alcohol and tobacco on risk of cancer of the mouth and pharynx. J. Chron. Dis., 25, 711–716

    PubMed  CAS  Google Scholar 

  42. Tuyns, A. J., Pequignot, G. and Jensen, O. M. (1977). Le cancer de l’oesophage en Ille-et- Vilaine en fonction des niveaux de consommation d’alcool et de tabac: des risques qui se multiplient. Bull. Cancer, 64, 45–60

    PubMed  CAS  Google Scholar 

  43. US Public Health Service (1982). The health consequences of smoking: cancer. A report of the Surgeon General. (Washington: U.S. Department of Health and Human Services)

    Google Scholar 

  44. Ibrahim, A. S. and Elsebai, I. (1983). Epidemiology of bladder cancer. In Elsebai, I. and Hoogstraten, B. (eds.) Bladder Cancer. Volume 1. General Review. CRC Series on Experiences in Clinical Oncology, pp. 17–37. (Boca Raton, Florida: CRC Press, Inc.)

    Google Scholar 

  45. El-Aaser, A. A. and El-Merzabani, M. M. (1983). Etiology of bladder cancer. In Elsebai, I. and Hoogstraten, B. (eds.) Bladder Cancer. Volume 1. General Review. CRC Series on Experiences in Clinical Oncology, pp. 39–58. (Boca Raton, Florida: CRC Press, Inc.)

    Google Scholar 

  46. Hicks, R. M. (1982). Nitrosamines as possible etiological agents in bilharzial bladder cancer. In Magee, P. N. (ed.) Nitrosamines and Human Cancer, Banbury Report 12. pp. 455–471. (New York: Cold Spring Harbor Laboratory)

    Google Scholar 

  47. Schwartz, D. A. (1980). Helminths in the induction of cancer: Opistherchis viverrini, Clonorchis sinersis and cholangiocarcinoma. Trop. Geogr. Med., 32, 95–100

    PubMed  CAS  Google Scholar 

  48. Land, C. (1980). Estimating cancer risks from low doses of ionising radiation. Science, 209, 1197–1203

    PubMed  CAS  Google Scholar 

  49. Kohn, H. I. and Fry, R. J. M. (1984). Radiation carcinogenesis. N. Engl. J. Med., 310, 504–511

    PubMed  CAS  Google Scholar 

  50. Smith, P. G. (1985). Radiation. In Vessey, M. P. and Gray, M. (eds.) Cancer Risks and Prevention. (Oxford: Oxford University Press)

    Google Scholar 

  51. Kato, H. and Schull, W. J. (1982). Studies of the mortality of A-bomb survivors. 7. Mortality, 1950–1978, Part 1: Cancer mortality. Radiat. Res., 90, 395–432

    PubMed  CAS  Google Scholar 

  52. Court Brown, W. M. and Doll, R. (1965). Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. Br. Med. J., ii, 1327–1332

    Google Scholar 

  53. Smith, P.G. and Doll, R. (1982). Mortality among patients with ankylosing spondylitis after a single treatment course with X-rays. Br. Med. J, 284, 449–460

    CAS  Google Scholar 

  54. UNSCEAR (1977). Sources and effects of ionising radiation. United Nations Scientific Committee on the Effects of Atomic Radiation. (New York: United Nations)

    Google Scholar 

  55. Jablon, S. and Bailar, J. C. (1980). The contribution of ionising radiation to cancer mortality in the United States. Prev. Med., 9, 219–226

    PubMed  CAS  Google Scholar 

  56. Day, N. E. (1984). Radiation and multistage carcinogenesis. In Boice, J. D. and Fraumeni, J. F. (eds.) Radiation Carcinogenesis: Epidemiology and Biological Significance. (New York: Raven Press)

    Google Scholar 

  57. Boice, J. D., Land, C. E., Share, R. E., Norman, J. E. and Takunaga, M. (1979). Risk of breast cancer following low dose radiation exposure. Radiology, 131, 559–597

    Google Scholar 

  58. Blum, H. (1959). Carcinogenesis by Ultraviolet Light. (Princeton: N.J.: Princeton University Press)

    Google Scholar 

  59. Muir, C. S. and Nectoux, J. (1982). Time trends: malignant melanoma of skin. In Magnus, K. (ed.) Trends in Cancer Incidence. (Washington: Hemisphere)

    Google Scholar 

  60. Okuda, K. and MacKay, I. (eds.) (1982). Hepatocellular Carcinoma, A Series of Workshops on the Biology of Human Cancer, Report No. 17, UICC Technical Report Series. Vol. 74. (Geneva: Unio International Contra Cancrum)

    Google Scholar 

  61. Munoz, N. and Linsell, C. A. (1982). Epidemiology of primary liver cancer. In Correa, P. and Haenszel, W. (eds.) Epidemiology of Cancer of the Digestive Tract, pp. 161–195. (The Hague, Boston, London: Martinus Nijhoff Publishers)

    Google Scholar 

  62. Beasley, R. P., Lin, C. C., Hwang, L. Y. and Chien, C. S. (1981). Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan. Lancet, ii, 1129–1132

    Google Scholar 

  63. Summers, J., Ogston, C. W., Jonak, G. J., Astrin, S. M., Tyler, G. V. and Snyder, R. L. (1984). Woodchuck hepatitis virus-induced hepatomas contain integrated and closed circular viral DNAs. In Giraldo, G. and Beth, E. (eds.) The Role of Viruses and Human Cancer. Volume II, pp. 213–225. (Amsterdam: Elsevier Science Publishers)

    Google Scholar 

  64. Mason, W. S., Halpern, M. S. and London, W. T. (1984). Hepatitis B viruses, liver disease and hepatocellular carcinoma. Cancer Surv., 3, 25–49

    Google Scholar 

  65. Blumberg, B. S. and London, W. T. (1985). Hepatitis B virus and the prevention of primary cancer of the liver. J. Natl Cancer Inst., 74, 267–273

    PubMed  CAS  Google Scholar 

  66. Shafritz, D. A. (1982). Hepatitis B virus DNA molecules in the liver of HBsAg carriers: mechanistic considerations in the pathogenesis of hepatocellular carcinoma. Hepatology, 2, 35S-41S

    Google Scholar 

  67. Ziemes, M., Garcia, P., Shaul, Y. and Rutter, W.J. (1985). Sequence of hepatitis B virus DNA incorporated into the genome of a human hepatoma cell line. J. Virol, 53, 885–892

    Google Scholar 

  68. Shaul, Y, Rutter, W. J. and Laub, O. (1985). A human hepatitis B viral enhancer element. EM BO J., 4, 427–430

    CAS  Google Scholar 

  69. Tiollais, P., Pourcel, C. and Dejean, A. (1985). The hepatitis B virus. Nature, 317,489–495

    PubMed  CAS  Google Scholar 

  70. Melbye, M. Skinhoj, P., Nielsen, N. H., Vestergaard, B.F., Ebbesen, P., Hansen, J. P. H. and Biggar, R. J. (1984). Virus-associated cancers in Greenland: frequent hepatitis B virus infection but low primary hepatocellular carcinoma incidence. J. Natl. Cancer Inst., 73, 1267–1272

    PubMed  CAS  Google Scholar 

  71. Szmuness, W. (1978). Hepatocellular carcinoma and hepatitis B virus: evidence for a causal association. Prog. Med. Virol, 24, 40–69

    PubMed  CAS  Google Scholar 

  72. Sun, T.-T. and Chu, Y.-Y. (1984). Carcinogenesis and prevention strategy of liver cancer in areas of prevalence. J. Cell Physiol, 3, 39–44

    CAS  Google Scholar 

  73. Hino, O., Kitagawa, T. and Sugano, H. (1985). Relationship between serum and histochemical markers for hepatitis B virus and rate of viral integration in hepatocellular carcinomas in Japan. Int. J. Cancer, 35, 5–10

    PubMed  CAS  Google Scholar 

  74. Busby, W. and Wogan, G. N. (1984). Aflatoxins. In Searle, C. E. (ed.) Chemical Carcinogens, ACS Monograph Series. No. 182, pp. 945–1136. (New York: American Cancer Society)

    Google Scholar 

  75. Peers, F. G. and Linsell, C. A. (1973). Dietary aflatoxins and liver cancer. A population based study in Kenya. Br. J. Cancer, 27, 473–484

    PubMed  CAS  Google Scholar 

  76. Van Rensburg, S. J., Cook-Mozaffari, P., Van Schalkwyk, D. J., Van Der Watt, J. J., Vincent, T. J. and Purchase, I. F. (1985). Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br. J. Cancer, 51, 713–726

    PubMed  Google Scholar 

  77. Burkitt, D. P. (1962). Determining the climatic limitations of a children’s cancer common in Africa. Br. Med. J., ii, 1019–1023

    Google Scholar 

  78. Epstein, M. A., Achong, B. G. and Baor, Y. M. (1964). Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet, i, 702–703

    Google Scholar 

  79. Lenoir, G. M., O’Conor, G. T. and Olweny, C. L. M. (eds.) (1985). Burkitt’s Lymphoma. IARC Scientific Publications. Vol. 60. (Lyon: International Agency for Research on Cancer)

    Google Scholar 

  80. Hirayama, T. (1978). Descriptive and analytical epidemiology of nasopharyngeal cancer. In De-The, G., Ito, Y. and Davis W. (eds.) Nasopharyngeal Carcinoma: Etiology and Control IARC Scientific Publications. Vol. 20, pp. 167–189. (Lyon: International Agency for Research on Cancer)

    Google Scholar 

  81. Ernberg, I. and Kallin, B. (1984). Epstein-Barr virus and its association with human malignant diseases. Cancer Surv., 3, 51–89

    Google Scholar 

  82. Thorley-Lawson, D. A., Edson, C. M. and Geilinger, K. (1982). Epstein-Barr virus antigens — a challenge to modern biochemistry. Adv. Cancer Res., 36, 338–343

    Google Scholar 

  83. Whittle, H. C., Brown, J., Marsh, K., Greenwood, B. M., Seidelin, P., Tighe, H. and Wedderburn, L. (1984). T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria. Nature, 312, 449–450

    PubMed  CAS  Google Scholar 

  84. Lenoir, G. and Taub, R. (1986). Chromosomal translocations and oncogenes in Burkitt’s lymphoma. In Goldman J. M. and Harnden, D. G. (eds.) Leukaemia and Lymphoma Research, 2. Genetic Rearrangements in Leukaemia and Lymphoma, pp. 152–172. (Edinburgh: Churchill Livingstone)

    Google Scholar 

  85. Smith, P. G. (1985). Rapporteur’s report. In Lenoir, G., O’Conor, G. and Olweny, C. I. M. (eds.) Burkitt’s Lymphoma. IARC Scientific Publications. Vol. 60. (Lyon: International Agency for Research on Cancer)

    Google Scholar 

  86. Ho, J. H. C., Huang, D. P. and Fong, Y. Y. (1978). Salted fish and nasopharyngeal carcinoma in Southern Chinese. Lancet, ii, 626

    Google Scholar 

  87. Armstrong, R. W., Armstrong, M. J., Yu, M. C. and Henderson, B. E. (1983). Salted fish and inhalants as risk factors for nasopharyngeal carcinoma in malaysian Chinese. Cancer Res., 43, 2967–2970

    PubMed  CAS  Google Scholar 

  88. Yu, M. C., Ho, J. H. C., Lai, S. H. and Henderson, B. E. (1986). Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res., 46, 956–961

    PubMed  CAS  Google Scholar 

  89. Gallo, R. C. (1984). Human T-cell leukaemia-lymphoma virus and T cell malignancies in adults. Cancer Surv., 3, 113–159

    Google Scholar 

  90. Gissmann, L. (1984). Papillomaviruses and their association with cancer in animals and man. Cancer Surv., 3, 161–181

    Google Scholar 

  91. Zur Hausen, H. and Schneider, A. (1985). The role of papillomaviruses in human anogenital cancer. In: Howley, P. and Solzman, N. P. (eds.) Papovaviridae, The Papillomaviruses. (New York: Plenum Press) (In press)

    Google Scholar 

  92. Vonka, V., Kanka, J., Jelinek, J., Subrt, I., Suchanek, A., Havrankova, A. et al. (1984). Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. I. Epidemiological characteristics. Int. J. Cancer, 33, 49–60

    PubMed  CAS  Google Scholar 

  93. Vonka, V., Kanka, J., Hirsch, I., Zavadova, H., Kromar, M., Suchankova, A. et al. (1984). Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. II. Herpes simplex type-2 antibody presence in sera taken at enrolment. Int. J. Cancer, 33, 61–66

    PubMed  CAS  Google Scholar 

  94. Tomatis, L. (1984). Exposures associated with cancer in humans. J. Cancer Res. Clin. Oncol., 108, 6–10

    PubMed  CAS  Google Scholar 

  95. Lilienfeld, A. M. (1983). Practical implications of epidemiologic methods. Environ. Health Perspet., 52, 3–8

    CAS  Google Scholar 

  96. Tomatis, L., Breslow, N. E. and Bartsch, H. (1982). Experimental studies in the assessment of human risk. In Schottenfeld, D. and Fraumeni, J. F. (eds.) Cancer Epidemiology and Prevention, pp. 44–73. (Philadelphia: W. B. Saunders Company)

    Google Scholar 

  97. Tomatis, L. (1977). The value of long-term testing for the implementation of primary prevention. In Hiatt, H. H., Watson, J. D. and Winsten, J. A. (eds.) Origins of Human Cancer, pp. 1339–1357. (New York: Cold Spring Harbor Laboratory)

    Google Scholar 

  98. Tomatis, L. (1985). The contribution of epidemiological and experimental data to the control of environmental carcinogens. Cancer Lett., 26, 5–16

    PubMed  CAS  Google Scholar 

  99. Meselson, M. and Russel, K. (1971). Comparisons of carcinogenic and mutagenic potency. In Hiatt, H. H., Watson, J. D. and Winsten, J. A. (eds.) Origins of Human Cancer, Book C: Human Risk Assessment, pp. 1473–1481. Cold Spring Harbor Conferences on Cell Proliferation, Vol. 4. (New York: Cold Spring Harbor)

    Google Scholar 

  100. Peto, R., Pike, M. C., Berstein, L., Gold, L. S. and Ames, B. N. (1984). The TD50: a proposed general convention for the numerical description of the carcinogenic potency of chemicals in chronic exposure animal experiments. Environ. Health Perspect., 58, 1–8

    PubMed  CAS  Google Scholar 

  101. Berlin, A., Draper, M., Hemminki, K. and Vainio, H. (1984). Monitoring Human Exposure to Carcinogenic and Mutagenic Agents. I ARC Scientific Publication. Vol. 59. (Lyon: International Agency for Research on Cancer)

    Google Scholar 

  102. Perera, F. P. and Weinstein, I. B. (1982). Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. J. Chron. Dis.,35, 581–600

    Google Scholar 

  103. Kriek, E. Engelse, L. D., Scherer, E. and Westra, J. G. (1984). Formation of DNA modifications by chemical carcinogens identification, localization and quantification. Biochim. Biophys. Acta, 738, 181–201

    PubMed  CAS  Google Scholar 

  104. International Agency for Research on Cancer/International Programme on Chemical Safety Working Group Report (1982). Development and possible use of immunological techniques to detect individual exposure to carcinogens. Cancer Res., 42, 5236–5239

    Google Scholar 

  105. Bartsch, H. and Montesano, R. (1984). Relevance of nitrosamines to human cancer. Carcinogenesis, 5, 1381–1393

    PubMed  CAS  Google Scholar 

  106. Forman, D., Al-Dabbagh, S. and Doll, R. (1985) Nitrates, nitrites and gastric cancer in Great Britain. Nature, 313, 620–625

    PubMed  CAS  Google Scholar 

  107. Yang, C. S. (1980). Research on esophageal cancer in China: a review. Cancer Res., 40, 2633–2644

    PubMed  CAS  Google Scholar 

  108. Lu, S. H., Ohshima, H. and Bartsch, H. (1985). Recent studies on JV-nitroso compounds as possible etiological factors in oesophageal cancer. In O’Neill, I.L., Von Borstel, R.C., Miller, C.T., Long, J. and Bartsch, H. (eds.) N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer. IARC Scientific Publication. Vol. 57, pp. 947–953. (Lyon: International Agency for Research on Cancer)

    Google Scholar 

  109. Umbenhauer, D., Wild, C. P., Montesano, R., Saffhill, R., Boyle, J. M., Huh, N., Kirstein, U., Thomale, J., Rajewsky, M. F. and Lu, S. H. (1985). 06-methyldeoxyguanosine in oesophageal DNA among persons at high risk of oesophageal cancer. Int. J. Cancer, 36, 661–665

    Google Scholar 

  110. Ohshima, H. and Bartsch, H. (1981) Quantitative estimation of endogenous nitrosation in humans by monitoring N-nitrosoproline excreted in the urine. Cancer Res., 41, 3658–3662

    PubMed  CAS  Google Scholar 

  111. Sugimura, T. and Sato, S. (1983). Mutagens-carcinogens in foods. Cancer Res., 43, 2415s-2421s

    Google Scholar 

  112. Ames, B. N. (1983). Dietary carcinogens and anticarcinogens. Science, 221, 1256–1264

    PubMed  CAS  Google Scholar 

  113. Sporn, M. B. and Roberts, A. B. (1983). Role of retinoids in differentiation and carcinogenesis. Cancer Res., 43, 3034–3040

    PubMed  CAS  Google Scholar 

  114. Peto, R., Doll, R., Buckley, J. D. and Sporn, M. D. (1981). Can dietary beta-carotene materially reduce human cancer rates? Nature, 290, 201–208

    PubMed  CAS  Google Scholar 

  115. Hennekens, C. H., Stampfer, M. J. and Willett, W. (1984). Micronutrients and cancer prevention. Cancer Detect. Prev., 7, 147–158

    PubMed  CAS  Google Scholar 

  116. Munoz, N., Wahrendorf, J., Lu, J. B., Crespi, M., Thurnham, D. I., Day, N. E., Zheng, H. J., Grassi, A., Li, W. Y., Liu, G. L., Lang, Y. Q., Zhang, C. Y., Zheng, S. F., Li, J. Y., Correa, P., O’Conor, G. T. and Bosch, X. (1985). No effect of riboflavine, retinol, and zinc on prevalence of precancerous lesion of oesophagus. Lancet, ii, 111–114

    Google Scholar 

  117. Stich, H. F., Hornby, P. and Dunn, B. P. (1985). A pilot beta-carotene intervention trial with inuits using smokeless tobacco. Int. J. Cancer, 36, 321–327

    PubMed  CAS  Google Scholar 

  118. Miller, A. B. and Bulbrook, R. D. (1980). The epidemiology and etiology of breast cancer. N. Engl. J. Med., 303, 1246–1248

    PubMed  CAS  Google Scholar 

  119. Pike, M. C., Krailo, M. D., Henderson, B. E., Casagrande, J. T. and Hoel, D. G. (1983). ’Hormonal’ risk factors, ’breast tissue age’ and the age-incidence of breast cancer. Nature, 303, 767–770

    Google Scholar 

  120. Nagasawa, H. (1985). Age-related changes in mammary gland DNA synthesis as a limiting factor for mammary tumorigenesis in rats and its implication for human breast cancer. In Likhachev, A., Anisimov, V. and Montesano, R. (eds.) Age-related Factors in Carcinogenesis. IARC Scientific Publications. Vol. 58, pp. 105–113. (Lyon: International Agency for Research on Cancer)

    Google Scholar 

  121. Cairns,J. (1975). Mutation selection and the natural history of cancer. Nature, 255, 197–200

    Google Scholar 

  122. Cuzick, J., Wares, D.Y. and Bulbrook, R.D. (1986). The prevention of breast cancer. Lancet, i, 33–86

    Google Scholar 

  123. IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Polynuclear Aromatic Compounds. Part 3. Some Complex Industrial Exposures in Aluminium Production, Coal Gasification, Coke Production, and Iron and Steel Founding. Vol. 34. (Lyon: International Agency for Research on Cancer)

    Google Scholar 

  124. IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans Polynuclear Aromatic Compounds. Part 4. Bitumens, Coal-tars and Derived Products. Shale-oils and Soots. Vol. 35. (Lyon: International Agency for Research on Cancer)

    Google Scholar 

  125. Silverberg, E. (1985). Cancer Statistics, 1985. Ca-A Cancer Journal for Clinicians, 35, 19–35

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 MTP Press Limited

About this chapter

Cite this chapter

Montesano, R., Parkin, D.M., Tomatis, L. (1987). Environmental causes of cancer in man. In: Waring, M.J., Ponder, B.A.J. (eds) Biology of Carcinogenesis. Cancer Biology and Medicine, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3213-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-3213-5_7

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7942-6

  • Online ISBN: 978-94-009-3213-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics